Stock ALDX ALDEYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
3.86 USD +3.49% Intraday chart for Aldeyra Therapeutics, Inc. -1.28% +9.97%
08/05 Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study MT
08/05 Aldeyra Therapeutics, Inc. Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ALDEYRA THERAPEUTICS, INC. Stock Aldeyra Therapeutics, Inc.
 23Cr - - - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.43TCr -
ARGENX SE Stock argenx SE
 2.2TCr -
GENMAB A/S Stock Genmab A/S
 1.82TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 1.64TCr
  1. Stock Market
  2. Equities
  3. ALDX Stock
  4. Charts Aldeyra Therapeutics, Inc.
  5. Sector Chart